Scientists probe genetic secrets of blood cancer to predict treatment success
NCT ID NCT07162532
Summary
This study aims to understand how specific genetic characteristics in patients with chronic lymphocytic leukemia (CLL) affect their response to treatment and overall health outcomes. Researchers will collect detailed medical history, perform physical exams, and analyze blood samples from 45 newly diagnosed adult patients to look for genetic markers. The goal is to identify patterns that can help predict which patients might respond better to certain treatments based on their genetic profile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.